% | $
Quotes you view appear here for quick access.

Noble Energy, Inc. Message Board

stimulatemypackage 2 posts  |  Last Activity: Feb 27, 2015 11:50 PM Member since: Mar 12, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • stimulatemypackage by stimulatemypackage Feb 27, 2015 11:50 PM Flag

    From the DPRX silce deck:

    Mild DFI

    Currently no FDA approved product

    Incidence: Approximately 650,000 patients annually (US)

    Locilex ® could become the standard of care

  • Reply to

    CEMP is an Investment

    by itrizia Feb 27, 2015 10:09 AM
    stimulatemypackage stimulatemypackage Feb 27, 2015 11:24 PM Flag

    DPRX is in Phase III trials for diabetic foot ulcers

    NEW YORK, Feb. 25, 2015 /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (DPRX), today announced that its two pivotal Phase 3 clinical trials, known as OneStep-1 and OneStep-2, have passed the 25% enrollment milestone, in the aggregate, with each study having enrolled nearly the same number of patients.

    The OneStep Phase 3 clinical trials are being conducted under a Special Protocol Assessment (SPA) agreement from the Food and Drug Administration (FDA) for evaluation of Locilex® (pexiganan cream 0.8%), the Company's novel, broad-spectrum topical antibiotic peptide for the treatment of patients with mild infections of diabetic foot ulcers.

28.73+0.82(+2.94%)Feb 12 4:00 PMEST